Why the study?
Does antichlamydial antibiotic therapy reduce mortality or cardiovascular events in patients with coronary artery disease?
Population
19,217 patients with coronary artery disease pooled from 11 prospective, randomized, placebo-controlled trials
Comparison
Antichlamydial antibiotic therapy vs Placebo
Design
Meta-analysis, randomized, placebo-controlled
Authors
Loading...
Antibiotic therapy confers no benefit on mortality or events in CAD; confirms lack of efficacy and ends pursuit of infection-targeted therapy.
Does antichlamydial antibiotic therapy reduce mortality or cardiovascular events in patients with coronary artery disease?
Antichlamydial antibiotic therapy does not provide clinical benefit in reducing mortality or cardiovascular events for patients with coronary artery disease.
Andraws et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: